Oregano and Basil Leaves and Coronary Artery Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-75
SponsorShahid Beheshti University of Medical Sciences
About this trial
The present study will examine the effects of increasing dietary polyphenol intake by consumption of oregano and basil leaves, on plasma inflammatory and lipid factors and total urinary polyphenol levels in patients who have recently had unstable angina.
Eligibility criteria
Qualifiers
Patients diagnosed with unstable angina
Disqualifiers
Patients diagnosed with STEMI
Patients undergoing coronary artery bypass grafting
Liver cirrhosis and advanced chronic kidney disease (CKD 5)
Having known inflammatory and autoimmune diseases, such as inflammatory bowel disease (IBD) and rheumatoid arthritis, or taking glucocorticoid medications
Trial design
Treatments tested in this trial
- Control (Standard treatment)
- Higher polyphenol intake by consumption of oregano and basil
Treatment groups
70 Participants
are divided into 2 treatment groupsLocations
1Imam Husain hospital TehranTehran Province, Iran
Sponsors and collaborators
Shahid Beheshti University of Medical Sciences
Lead sponsor
Source ClinicalTrials.gov